Emerging evidence highlights the significance of NK cell infiltration, cytotoxicity, and ligand-receptor dynamics-such as NKG2D, KIRs, and CX3CR1<sup>+</sup> subsets-in shaping prognosis and therapeutic responsiveness in glioma patients. The gene discussed is CX3CR1; the disease is central nervous system cancer.